Fluoride and dialysis osteodystrophy: results of a double-blind study.
D000469:Alkaline Phosphatase / Q000097:blood; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D002119:Calcium Carbonate / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D005260:Female; D005459:Fluorides / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010018:Osteomalacia / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D011792:Quebec; D011859:Radiography; D006435:Renal Dialysis; D014881:Water Supply
D010281:Parathyroid Hormone; D010758:Phosphorus; D000536:Aluminum Hydroxide; D003404:Creatinine; D000469:Alkaline Phosphatase; D002119:Calcium Carbonate; D005459:Fluorides; D002118:Calcium